BioLine RX Ltd ADR buy Quitte
Start price
17.05.18
/
50%
€182.03
Target price
05.06.18
€270.00
Performance (%)
-3.21%
End price
05.06.18
€176.18
Summary
This prediction ended on 05.06.18 with a price of €176.18. With a performance of -3.21%, the BUY prediction for BioLine RX Ltd ADR by Quitte closed slightly in the red. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioLine RX Ltd ADR | 6.250% | 6.250% | -54.667% | -70.940% |
iShares Core DAX® | 0.597% | 3.083% | 16.090% | 16.439% |
iShares Nasdaq 100 | 0.899% | 5.338% | 29.239% | 56.431% |
iShares Nikkei 225® | 1.775% | -1.206% | 6.823% | 4.774% |
iShares S&P 500 | 0.990% | 3.500% | 24.956% | 47.182% |
Comments by Quitte for this prediction
In the thread BioLine RX Ltd ADR diskutieren
könnte langsam was werden
(Vom Mitglied beendet)